FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
EMIT 2000 TOBRAMYCIN ASSAY EMIT 2000 TOBRAMYCIN CALIBRATORS
K Number: K003341
·
Decision Jan 22, 2001
Classifications
1
FEI Numbers
8
Registration Numbers
8
Same Product Code
22
Applicant Total
19
Review Days
89
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- EMIT 2000 TOBRAMYCIN ASSAY EMIT 2000 TOBRAMYCIN CALIBRATORS
- K Number
- K003341
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 862.3900
- Medical Specialty
- Clinical Toxicology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Syva Co., Dade Behring, Inc.
- Date Received
- October 25, 2000
- Decision Date
- January 22, 2001
- Product Code
- KLB
- Advisory Committee
- Clinical Toxicology
- Review Advisory Committee
- CH
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| KLB | Radioimmunoassay, Tobramycin | FDA class 2 | Clinical Toxicology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (KLB), ordered by most recent decision date.
ONLINE TDM TOBRAMYCIN
FDA 510(k)
FDA Class 2
·Clinical Toxicology
IMMULITE 2000 TOBRAMYCN, MODELS L2KTC2 (2002 TESTS), L2KTC6 (600 TESTS)
FDA 510(k)
FDA Class 2
·Clinical Toxicology
DUPONT DIMENSION(R) TOBRAMLLYCIN(TOBR) METHOD
FDA 510(k)
FDA Class 2
·Clinical Toxicology
IL TOBRAMYCIN ASSAY
FDA 510(k)
FDA Class 2
·Clinical Toxicology
TECHNICON RA SYSTEMS TOBRAMYCIN TEST METHOD
FDA 510(k)
FDA Class 2
·Clinical Toxicology
EMIT CONVENIENCE PACK: TOBRAMYCIN ASSAY
FDA 510(k)
FDA Class 2
·Clinical Toxicology
Other Clearances by Syva Co., Dade Behring, Inc.
| K Number | Device Name | ||
|---|---|---|---|
| K011920 | EMIT 2000 DIGOXIN ASSAY, MODEL OSR4H229 | Jul 2, 2001 | Substantially Equivalent |
| K011620 | EMIT 2000 N-ACETYLPROCAINAMIDE ASSAY, MODEL OSR4N229 | Jun 18, 2001 | Substantially Equivalent |
| K011605 | EMIT 2000 QUINIDINE ASSAY, MODEL OSR4Q229 | Jun 12, 2001 | Substantially Equivalent |
| K011300 | EMIT II PLUS CANNABINOID ASSAY, MODEL OSR9N229 | May 17, 2001 | Substantially Equivalent |
| K011306 | EMIT II PLUS BENZODIAZEPINE ASSAY, MODEL 0SR9F229 | May 16, 2001 | Substantially Equivalent |
| K011161 | MODIFICATION TO THE EMIT II PLUS PHENCYCLIDINE ASSAY, MODEL OSR9J229 | May 15, 2001 | Substantially Equivalent |
| K011289 | EMIT II PLUS OPIATE ASSAY, MODEL OSR9B229 | May 15, 2001 | Substantially Equivalent |
| K011163 | MODIFICATION TO THE EMIT II PLUS PROPOXYPHENE ASSAY, MODEL OSR9G229 | May 10, 2001 | Substantially Equivalent |
| K011166 | MODIFICATION TO EMIT 2000 THEOPHYLLINE ASSAY, MODEL OSR 4P229 | May 10, 2001 | Substantially Equivalent |
| K011164 | MODIFICATION TO THE EMIT II PLUS METHAQUALONE ASSAY, MODEL OSR9Q229 | May 10, 2001 | Substantially Equivalent |